CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-15 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −22,068 | 165,852 | ||
| 2024-11-15 | Miljkovic Milos Chief Medical Officer | Option exercise | +20,000 | $3.23 | $65K | 38,273 |
| 2024-11-15 | Miljkovic Milos Chief Medical Officer | Sale | −20,000 | $17.14 | $343K | 18,273 |
| 2024-11-15 | Miljkovic Milos Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 30,528 | ||
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Option exercise | +16,065 | $3.23 | $52K | 42,005 |
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Sale | −16,065 | $17.06 | $274K | 25,940 |
| 2024-11-15 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −16,065 | 90,432 | ||
| 2024-11-14 | SPRINGER TIMOTHY A Director | Purchase | +74,157 | $16.19 | $1.2M | 8,097,923 |
| 2024-11-14 | SPRINGER TIMOTHY A Director | Purchase | +22,242 | $16.97 | $377K | 8,120,165 |
| 2024-11-14 | Kurtoglu Metin Chief Technology Officer | Option exercise | +25,900 | $1.41 | $37K | 76,933 |
| 2024-11-14 | Kurtoglu Metin Chief Technology Officer | Sale | −21,900 | $16.33 | $358K | 55,033 |
| 2024-11-14 | Kurtoglu Metin Chief Technology Officer | Sale | −4,000 | $17.06 | $68K | 51,033 |
| 2024-11-14 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −25,900 | 187,920 | ||
| 2024-11-14 | Miljkovic Milos Chief Medical Officer | Option exercise | +35,000 | $3.23 | $113K | 53,273 |
| 2024-11-14 | Miljkovic Milos Chief Medical Officer | Sale | −35,000 | $16.13 | $565K | 18,273 |
| 2024-11-14 | Miljkovic Milos Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −35,000 | 50,528 | ||
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Option exercise | +36,050 | $3.23 | $116K | 61,990 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Sale | −18,550 | $16.34 | $303K | 43,440 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Sale | −17,500 | $17.02 | $298K | 25,940 |
| 2024-11-14 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −36,050 | 106,497 |
Page 8 of 16 · 316 trades